E-LIB Suche - Ergebnisse für: Wilding, John PH

1

Obesity: medical management:

Henney, Alex E. ; Wilding, John PH.
Medicine. , 2023

Link: https://doi.org/10.1016/..

2

A randomised, controlled, double blind study to assess mech..:

Brown, Emily ; Wilton, Moon M ; Sprung, Victoria S...
BMJ Open. 11 (2021) 7 - p. e045663 , 2021

Link: https://doi.org/10.1136/..

3

Dapagliflozin for the treatment of type 2 diabetes mellitus..:

Nicholson, Martha K ; Ghazal Asswad, Randa ; Wilding, John PH
Expert Opinion on Pharmacotherapy. 22 (2021) 17 - p. 2303-2310 , 2021

Link: https://doi.org/10.1080/..

4

Randomised, cOntrolled Multicentre trial of 26 weeks subcut..:

Sprung, Victoria S ; Kemp, Graham J ; Wilding, John PH...
BMJ Open. 10 (2020) 7 - p. e038856 , 2020

Link: https://doi.org/10.1136/..

5

The design and rationale for the Dapagliflozin Effect on Ca..:

Wiviott, Stephen D. ; Raz, Itamar ; Bonaca, Marc P...
American Heart Journal. 200 (2018) - p. 83-89 , 2018

Link: https://doi.org/10.1016/..

6

Combination therapy for obesity:

Wilding, John PH
Journal of Psychopharmacology. 31 (2017) 11 - p. 1503-1508 , 2017

Link: https://doi.org/10.1177/..

7

Serum urate and obstructive sleep apnoea in severe obesity:

Seetho, Ian W ; Parker, Robert J ; Craig, Sonya...
Chronic Respiratory Disease. 12 (2015) 3 - p. 238-246 , 2015

Link: https://doi.org/10.1177/..

8

Urinary proteomic profiling in severe obesity and obstructi..:

Seetho, Ian W ; Ramírez-Torres, Adela ; Albalat, Amaya...
Sleep Science. 8 (2015) 2 - p. 58-67 , 2015

Link: https://doi.org/10.1016/..

9

Sleep-disordered breathing, type 2 diabetes and the metabol..:

Seetho, Ian W ; Wilding, John PH
Chronic Respiratory Disease. 11 (2014) 4 - p. 257-275 , 2014

Link: https://doi.org/10.1177/..

10

Modern management of obesity:

Aditya, Bhandari Sumer ; Wilding, John PH
Clinical Medicine. 9 (2009) 6 - p. 617-621 , 2009

Link: https://doi.org/10.7861/..

11

Differential vascular dysfunction in response to diets of d..:

Fatani, Sameer ; Pickavance, Lucy C ; Sadler, Claire J...
Nutrition & Metabolism. 4 (2007) 1 - p. , 2007

Link: https://doi.org/10.1186/..

12

Tesaglitazar, as add-on therapy to sulphonylurea, dose-depe..:

Wilding, John PH ; Gause-Nilsson, Ingrid ; Persson, Anders
Diabetes and Vascular Disease Research. 4 (2007) 3 - p. 194-203 , 2007

Link: https://doi.org/10.3132/..

13

Pathophysiology and Aetiology of Obesity:

Wilding, John PH
Medicine. 31 (2003) 4 - p. 1-4 , 2003

Link: https://doi.org/10.1383/..

14

Weight regain and cardiometabolic effects after withdrawal ..:

Wilding, John PH ; Batterham, Rachel L ; Davies, Melanie...
https://discovery.ucl.ac.uk/id/eprint/10149199/1/Diabetes%20Obesity%20Metabolism%20-%202022%20-%20Wilding%20-%20Weight%20regain%20and%20cardiometabolic%20effects%20after%20withdrawal%20of%20semaglutide%20.pdf. , 2022

Link: https://discovery.ucl.ac..

15

The Place and Value of Sodium-Glucose Cotransporter 2 Inhib..:

Wilding, John PH ; Evans, Marc ; Fernando, Kevin...
doi:10.17863/CAM.83710. , 2022

Link: https://doi.org/10.17863..